These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 23280316)

  • 21. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
    Noguchi T; Toiyama Y; Kitajima T; Imaoka H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Toden S; Kusunoki M
    Oncology; 2016; 90(4):221-31. PubMed ID: 26999740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of microRNA-16 expression in human colorectal cancer.
    Qian J; Jiang B; Li M; Chen J; Fang M
    World J Surg; 2013 Dec; 37(12):2944-9. PubMed ID: 24045965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
    Bai R; Weng C; Dong H; Li S; Chen G; Xu Z
    Int J Cancer; 2015 Nov; 137(10):2310-22. PubMed ID: 25991585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
    Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-519d-3p inhibits cell proliferation and migration by targeting TROAP in colorectal cancer.
    Ye X; Lv H
    Biomed Pharmacother; 2018 Sep; 105():879-886. PubMed ID: 30021381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
    Tokarz P; Blasiak J
    Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
    Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
    Wang D; Li Y; Zhang C; Li X; Yu J
    J Cell Biochem; 2018 Feb; 119(2):1755-1766. PubMed ID: 28786533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.
    Qiu Z; Guo W; Wang Q; Chen Z; Huang S; Zhao F; Yao M; Zhao Y; He X
    Gastroenterology; 2015 Nov; 149(6):1587-1598.e11. PubMed ID: 26248089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.
    Nakata W; Uemura M; Sato M; Fujita K; Jingushi K; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
    Oncotarget; 2015 Aug; 6(25):21645-54. PubMed ID: 26046464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
    Ghanbari R; Mosakhani N; Asadi J; Nouraee N; Mowla SJ; Poustchi H; Malekzadeh R; Knuutila S
    Cancer Biomark; 2015; 15(2):189-95. PubMed ID: 25519020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation.
    Jones MF; Hara T; Francis P; Li XL; Bilke S; Zhu Y; Pineda M; Subramanian M; Bodmer WF; Lal A
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1550-8. PubMed ID: 25775580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.